These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 2940959

  • 1. [Combined anti-androgen treatment in adenocarcinoma of the prostate: first use of a new therapeutically efficacious principle in hormone-dependent cancer].
    Labrie F, Dupont A, Bélanger A, Lacourcière Y, Monfette JE, Monfette G.
    Ann Urol (Paris); 1986; 20(2):98-106. PubMed ID: 2940959
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Combination therapy with flutamide and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patients.
    Labrie F, Dupont A, Giguere M, Borsanyi JP, Lacourciere Y, Belanger A, Lachance R, Emond J, Monfette G.
    J Steroid Biochem; 1987; 27(1-3):525-32. PubMed ID: 2961937
    [Abstract] [Full Text] [Related]

  • 4. [New approach in the treatment of prostatic cancer: combined use of a LHRH agonist and an androgen antagonist].
    Labrie F, Dupont A, Belanger A, Lefebvre FA, Raynaud JP.
    J Pharmacol; 1983; 14 Suppl 3():117-35. PubMed ID: 6423907
    [Abstract] [Full Text] [Related]

  • 5. Combination therapy with flutamide and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patients with advanced prostate cancer.
    Labrie F, Dupont A, Giguère M, Borsanyi JP, Lacourciere Y, Bélanger A, Lachance R, Emond J, Monfette G.
    Prog Clin Biol Res; 1988; 260():41-62. PubMed ID: 3283766
    [Abstract] [Full Text] [Related]

  • 6. Combination therapy with flutamide and castration (LHRH agonist or orchiectomy) in previously untreated patients with clinical stage D2 prostate cancer: today's therapy of choice.
    Labrie F, Dupont A, Cusan L, Giguere M, Bergeron N, Borsanyi JP, Lacourciere Y, Belanger A, Emond J, Monfette G.
    J Steroid Biochem; 1988; 30(1-6):107-17. PubMed ID: 3290578
    [Abstract] [Full Text] [Related]

  • 7. Hormone therapy of prostatic bone metastases.
    Huben RP.
    Adv Exp Med Biol; 1992; 324():305-16. PubMed ID: 1492625
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Complete androgen blockade for the treatment of prostate cancer.
    Labrie F, Dupont A, Belanger A.
    Important Adv Oncol; 1985; ():193-217. PubMed ID: 3916740
    [No Abstract] [Full Text] [Related]

  • 11. Combination therapy using LHRH and somatostatin analogues plus dexamethasone in androgen ablation refractory prostate cancer patients with bone involvement: a bench to bedside approach.
    Koutsilieris M, Bogdanos J, Milathianakis C, Dimopoulos P, Dimopoulos T, Karamanolakis D, Halapas A, Tenta R, Katopodis H, Papageorgiou E, Pitulis N, Pissimissis N, Lembessis P, Sourla A.
    Expert Opin Investig Drugs; 2006 Jul; 15(7):795-804. PubMed ID: 16787142
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Combination therapy in stage C and D prostatic cancer: rationale and five year clinical experience.
    Labrie F, Dupont A, Bélanger A, Cusan L, Giguère M, Lacourcière Y, Luthy I, Bégin D, Labrie C, Simard J.
    Cancer Metastasis Rev; 1987 Jul; 6(4):615-36. PubMed ID: 3327635
    [Abstract] [Full Text] [Related]

  • 16. Total androgen ablation: American experience.
    Crawford ED, Nabors WL.
    Urol Clin North Am; 1991 Feb; 18(1):55-63. PubMed ID: 1899495
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Keyrole of endocrinology in the victory against prostate cancer].
    Labrie F.
    Bull Cancer; 2006 Sep; 93(9):949-58. PubMed ID: 16980238
    [Abstract] [Full Text] [Related]

  • 19. Effect of the nonsteroidal antiandrogen nilutamide on adrenal androgen secretion.
    Decensi A, Torrisi R, Marroni P, Pensa F, Padovani P, Boccardo F.
    Prostate; 1994 Sep; 24(1):17-23. PubMed ID: 8290386
    [Abstract] [Full Text] [Related]

  • 20. Treatment of prostate cancer with gonadotropin-releasing hormone agonists.
    Labrie F, Dupont A, Bélanger A, St-Arnaud R, Giguère M, Lacourcière Y, Emond J, Monfette G.
    Endocr Rev; 1986 Feb; 7(1):67-74. PubMed ID: 3514203
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.